Bain Capital Life Sciences Investors, LLC Annexon, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $370 Million
- Q4 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 5,249,069 shares of ANNX stock, worth $14.9 Million. This represents 7.27% of its overall portfolio holdings.
Number of Shares
5,249,069
Previous 8,449,748
37.88%
Holding current value
$14.9 Million
Previous $50 Million
46.17%
% of portfolio
7.27%
Previous 8.98%
Shares
9 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$21 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.8 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.8 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.9 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $135M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...